CRAVIOTTO, Luisa

CRAVIOTTO, Luisa  

Dipartimento di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 34 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
A case of evolution of cutaneous mastocytosys into indolent systemic mastocytosis without evidence of c-kit mutation asp-816-val 1-gen-2011 E., Rossetti; Caramatti, Cecilia; Mattia, Lucia; Craviotto, Luisa; Zannoni, Marco; S., Bonomini; F., Russo; M., Mangoni
A distintive nuclear morfology in three cases of acute myeloid leukaemia associated with loss HLA-DR expression and FTL3 internal tandem duplication 1-gen-2008 Caramatti, Cecilia; Bonomini, S; Ferraro, F; Rossetti, E; Sammarelli, G; Zannoni, Marco; Pietra, S; Mattia, L; Craviotto, Luisa; Mangoni, L; Rizzoli, Vittorio
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis 1-gen-2005 Giuliani, Nicola; Simona, Colla; Francesca, Morandi; Sabrina, Bonomini; Lazzaretti, Mirca; Cristina, Mancini; Monica, Crugnola; Tagliaferri, Sara; Rita, Rizzato; Eugenia, Martella; Sammarelli, Gabriella; Craviotto, Luisa; Caramatti, Cecilia; Mangoni, Marcellina; Rizzoli, Vittorio
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 1-gen-2014 Bolzoni, Marina; Storti, Paola; Guasco, D; Ronchetti, D; Agnelli, L; Costa, Federica; Bonomini, S; Dalla Palma, B; Craviotto, Luisa; Neri, A; Aversa, Franco; Giuliani, Nicola
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 1-gen-2016 DALLA PALMA, ANNA BENEDETTA; Marchica, Valentina; Accardi, F; Guasco, Daniela; Notarfranchi, L; Costa, Federica; Caviola, M; DE LUCA, Federica; Craviotto, Luisa; Pedrazzoni, Mario; Aversa, Franco; Giuliani, Nicola
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 1-gen-2016 Quaini, Federico; Fioretzaki, Rodanthi; Monica, Crugnola; Falco, Angela; Madeddu, Denise; Craviotto, Luisa; Cambo', Benedetta; Prezioso, Lucia; Sammarelli, Gabriella; Todaro, Giannalisa; Graiani, Gallia; Cristina, Mancini; Eugenia, Martella; Re, Francesca; Giuliani, Nicola; Aversa, Franco
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 1-gen-2020 Storti, P.; Vescovini, R.; Costa, F.; Marchica, V.; Toscani, D.; Dalla Palma, B.; Craviotto, L.; Malavasi, F.; Giuliani, N.
[Clinical applications of autologous bone marrow transplants. Technical aspects and purification] 1-gen-1985 Mangoni, L; Degliantoni, G; Malice, A; Craviotto, L; Rizzoli, V
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia 1-gen-2004 Colla, S; Sammarelli, Gabriella; Crugnola, M; Ascani, S; Sabbatini, E; Bonomini, S; Hojden, M; Craviotto, Luisa; DE CELIS, I; Morandi, F; Caramatti, Cecilia; Rizzoli, Vittorio; Giuliani, Nicola
Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. 1-gen-1992 Carlo Stella, C; Mangoni, L; Almici, C; Garau, D; Craviotto, Luisa; Piovani, G; Caramatti, Cecilia; Rizzoli, Vittorio
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 1-gen-2015 Toscani, Denise; Bolzoni, Marina; Costa, Federica; Quarona, Valeria; Marchica, Valentina; Mancini, Cristina; Martella, Eugenia; Bonomini, Sabrina; Storti, Paola; Chillemi, Antonella; Accardi, Fabrizio; Dalla Palma, Benedetta; Craviotto, Luisa; Malavasi, Fabio; Aversa, Franco; Giuliani, Nicola
GOOD IMMUNOLOGICAL RECONSTITUTION IN ADULTS WITH ACUTE LEUKEMIA AFTER.LFA-BETA TCR/CD19+DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) 1-gen-2017 Prezioso, L; Bonomini, S; Schifano, C; Monti, A; Manfra, Ilenia; Spolzino, A; Sammarelli, G; Craviotto, Luisa; Sassi, M; Soli, M; Aversa, Franco
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells 1-gen-2019 Prezioso, L.; Manfra, I.; Bonomini, S.; Schifano, C.; Segreto, R.; Monti, A.; Sammarelli, G.; Todaro, G.; Sassi, M.; Bertaggia, I.; Pelagatti, L.; Cambo, B.; Spolzino, Angelica; Follini, E.; Re, F.; Crugnola, M.; Craviotto, L.; Russo, F.; Plenteda, C.; Roti, G.; Giuliani, N.; Aversa, F.
Haploidentical stem cell transplantation after negative depletion of T cells expressing the alfabeta chain of the T-cell receptor (TRC) for adults with haematological malignamcies 1-gen-2013 L. Prezioso, S. Bonomini; Lambertini, C.; Schifano, C.; Rossetti, E.; Monti, A.; Todaro, G.; Sammarelli, Gabriella; Sassi, M.; Craviotto, Luisa; Masselli, Elena; Caramatti, Cecilia; Aversa, Franco
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 1-gen-2003 Giuliani, Nicola; Caramatti, Cecilia; Roti, Giovanni; Gaeta, A.; Colla, S.; Bonomini, S.; Hojden, M.; LA MONICA, S.; Sammarelli, Gabriella; Lazzaretti, Mirca; Craviotto, Luisa; Mangoni, Marcellina; Rizzoli, Vittorio
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 1-gen-2008 Colla, S; Storti, Paola; Donofrio, Gaetano; Lazzaretti, Mirca; Bonomini, S; Lunghi, Paolo; Crugnola, M; Bolzoni, Marina; Galla, L; Ippolito, L; Martella, E; Sammarelli, Gabriella; Craviotto, Luisa; Caramatti, Cecilia; Mangoni, Marcellina; Bonati, A; Rizzoli, Vittorio; Giuliani, Nicola
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 1-gen-2009 Storti, Paola; Colla, S; Donofrio, Gaetano; Lazzaretti, Mirca; Bonomini, S; Crugnola, M.; Bolzoni, Marina; Sgobba, V; Abeltino, M; Lunghi, Paolo; Ippolito, L; Martella, E; Sammarelli, Gabriella; Craviotto, Luisa; Caramatti, Cecilia; Mangoni, Marcellina; Bonati, A; Rizzoli, Vittorio; Giuliani, Nicola
Impact of interferon at induction chemotherapy and maintenance treatment for multiple myeloma preliminary results of a multicenter study by the italian non-hodgkin's lymphoma cooperative study group (NHLCSG) 1-gen-1994 Capnist, G.; Vespignani, M.; Spriano, M.; Damasio, E.; Craviotto, L.; Rizzoli, V.; Contu, A.; Olmeo, N.; Tedeschi, L.; Fabris, P.; Chisesi, T.
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 1-gen-2015 Masselli, Elena; Carubbi, Cecilia; Gobbi, Giuliana; Mirandola, Prisco; Galli, Daniela; Martini, Silvia; Pozzi, Giulia; Gildone, Maria; Albanese, Cristina; Bonomini, Sabrina; Crugnola, Monica; Craviotto, Luisa; Aversa, Franco; Vitale, Marco
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma 1-gen-2021 Romano, A.; Storti, P.; Marchica, V.; Scandura, G.; Notarfranchi, L.; Craviotto, L.; Di Raimondo, F.; Giuliani, N.